SANYO

Fact

Among the many environmental awards SANYO has received in the past are the Stratospheric Ozone Protection Awards from the U.S. Environmental Protection Agency (EPA) and the Chairman's Awards from the Recycling Promotion Conference.

Case Studies

  • Stanford University School of Medicine Stanford University School of Medicine (138.41 KB) The Herzenberg laboratory operates broadly across traditional barriers to do research that ranges from basic molecular, genetic, and cell based studies to clinical trials and patient studies in diseases involving immunological and redox abnormalities. They have recently published a series of studies collectively showing that freshly isolated lymphocytes, macrophages and fibroblasts respond more similarly in vitro and in vivo when the cells are cultured at incubator oxygen levels (5-10% O2) that more closely approximate the oxygen level that cells encounter in vivo.
  • Colorado Center for Reproductive Medicine Colorado Center for Reproductive Medicine (347.23 KB) The Colorado Center for Reproductive Medicine (CCRM) is one of the nation’s leading fertility clinics, providing a wide variety of infertility treatments ranging from basic care to the most advanced in vitro fertilization (IVF) technology available. For the past two decades, Dr. Gardner’s research has focused on the physiology and metabolism of the mammalian embryo.
  • Cell Therapy Processing Facility, Northwestern Memorial Hospital Cell Therapy Processing Facility, Northwestern Memorial Hospital (352.78 KB) The Cell Therapy Processing Facility at Northwestern Memorial Hospital in Chicago, IL is part of an NIH funded study consisting of 7 instrumental institutes across the country granted 8 million dollars each to demonstrate the processing and production of islet cells for transplantation of the pancreas in hopes of finding a cure to diabetes.
  • Baylor Institute for Immunology Research Baylor Institute for Immunology Research (245.38 KB) Baylor Institute for Immunology Research uses SANYO Biomedical Equipment for Dendritic Cell Immunology Research. BIIR has manufactured vaccines for clinical trials in dedicated Class 10,000 (ISO 7) cleanrooms.  Current vaccines being produced for clinical trials at BIIR are for stage 4 melanoma and HIV patients in which patients’ own DCs are cultivated and matured to provide a patient-specific treatment. The cleanroom design was driven by selecting equipment that would accommodate most of the existing and anticipated DC vaccine processes and was flexible enough to house future changes in the required equipment. The facility can accommodate 500 patients (12,000 individual vaccine vials) per year.
  • University of California San Diego- Department of Pharmacology University of California San Diego- Department of Pharmacology (235KB)

    Pharmacology is broadly defined as a discipline that investigates the effects of chemical interventions on biological systems. The UCSD program is renowned for its strength in elucidating basic cellular and molecular mechanisms of signal transduction that lead to drug target identification and ultimately to drug discovery. "We have used various kinds of tissue culture incubators from different vendors and there is just no comparison. Cell growth is more stable and the SANYO technology and design have greatly reduced contamination. We work specifically in signaling pathways, inflammation, cancer and metabolic diseases where a cell sample's environment is critical," said Anne Chang, UCSD Lab Manager. Every single one of our incubators is now a SANYO.

  • The Southern California Institute for Reproductive Sciences (IVF) The Southern California Institute for Reproductive Sciences (IVF) (788KB)

    The Southern California Institute for Reproductive Sciences is an independent, full service in vitro fertilization (IVF) laboratory working with several physicians specializing in the treatment of infertility. The Newport Beach facility has been open since 1992 and performs over 700 embryo transfer procedures annually. Treatment options include IVF, egg donation, surrogacy, intracytoplasmic sperm injection (ICSI), blastocyst transfer, and preimplantation genetic diagnosis (PGD). "Currently, we have 12 miniature SANYO MCO-5M incubators that can easily handle 600 fresh IVF and ICSI cases per year. We plan to get 6 more SANYO incubators to ensure individualized patient management for future growth," said Mitchel Schiewe, M.S., Ph.D., HCLD (ABB), ELD (ABB), Laboratory Director..


Page Top